Breath-Based AI Test Achieves 89.8% Sensitivity and 91.8% Specificity in Breast Cancer Screening — Results Presented at the 34th Annual Meeting of the Japanese Breast Cancer Society
NEWS
Exhibited at Taiwan’s International Medical Trade Fair “Medical Taiwan 2026” — Introducing Breath-Analysis AI Technology in the “M-novator” Innovation Zone
Joint Exhibition of “Near-Future Breast Cancer Screening Through Breath Analysis” at Expo 2025 Osaka, Kansai
Former TANITA President Daisuke Tanida Joins as Chief Strategy Officer (CSO)